Lunai Bioworks

LNAINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.927 M

$2.41 -0.41%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$178.0M

Loss-making

Shares outstanding

36,271,119

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#427Kiora PharmaceuticalsKPRX$11.7M
#428BullFrog AIBFRG$10.9M
#429Lunai BioworksLNAI$10.9M
#430Theriva BiologicsTOVX$10.1M
#431Aspire BiopharmaASBP$10.0M

Where these numbers come from

Share counts and financials for Lunai Bioworks are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.